Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy
NCT02793687
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Ischemic Stroke
Interventions
DRUG:
Mexidol
OTHER:
Placebo
Sponsor
Pharmasoft